RBM38 and ovarian carcinoma: In many studies, RNPC1 was recognized as an oncogene, frequently amplified in prostate cancer [19,20], ovarian cancer [21], colorectal cancer [22,23], chronic lymphocytic leukemia [24], colon carcinoma [25], esophageal cancer [26], dog lymphomas [17], and breast cancer [27,28].